Sign inJoin waitlistJoin the waitlist

CM

Chinedu Mmeje

Physician · Banner Gateway Medical Center

Credentials: · · · ·

History

Banner Gateway Medical Center
Present

University of Texas M D Anderson Cancer Center
2016–2017
Urology
Mayo Clinic College of Medicine and Science
2011–2016
Doctor of Medicine
2005–2009

Research

Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis
Scientific Reports · 2017 · 49 citations
Age-stratified outcomes of holmium laser enucleation of the prostate
BJU international · 2013 · First of 4 authors · 44 citations
Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy
BJU international · 2018 · First of 10 authors · 34 citations

Ashish Kamat
6 papers
Mitchell Humphreys
6 papers
RN
Rafael Nunez-Nateras
6 papers · 1 as a fellow
EC
Erik Castle
4 papers
Colin Dinney
3 papers
JW
Jonathan Warner
3 papers · 3 as a resident
Michael Woods
2 papers
Neema Navai
2 papers
Paul Andrews
2 papers
Aaron Martin
1 paper · 1 as a fellow
Angela Smith
1 paper · 1 as a resident
AP
Anthony Polcari
1 paper · 1 as a resident

Clinical trials

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2027
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2028
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Site PI · Recruiting · Phase 2
CG Oncology, Inc.
2024–2027
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2021–2033